Celgene Arthritis Treatment Meets Primary Goals in Study
Celgene Arthritis Treatment Meets Primary Goals in Study NASDAQ.com
View ArticleCelgene's Drug Pipeline News Soothes Investor Worries
Celgene's Drug Pipeline News Soothes Investor Worries Investors.com
View ArticleRevlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy Motley Fool
View ArticleCelgene drug shown to be effective, safe in psoriasis trial
Celgene drug shown to be effective, safe in psoriasis trial Reuters
View Article2 Sides of Celgene's Apremilast Results
2 Sides of Celgene's Apremilast Results Motley Fool
View ArticleCan New Psoriasis Drugs Scratch Investors' Itch?
Can New Psoriasis Drugs Scratch Investors' Itch? Investors.com
View ArticleIs Celgene's Apremilast A Potential Blockbuster Or Not?
Is Celgene's Apremilast A Potential Blockbuster Or Not? Seeking Alpha
View ArticleCelgene: Apremilast For Psoriatic Arthritis Offers Upside
Celgene: Apremilast For Psoriatic Arthritis Offers Upside Seeking Alpha
View ArticleNew Data Improves Sales Outlook For Celgene's Apremilast
New Data Improves Sales Outlook For Celgene's Apremilast TheStreet.com
View ArticleCelgene arthritis drug appears effective, safe after 1 year -study
Celgene arthritis drug appears effective, safe after 1 year -study Yahoo/Reuters
View ArticleCelgene unit announces apremilast phase III study results
Celgene unit announces apremilast phase III study results The Fly on the Wall
View ArticleWill the New Arthritis Drug Help Celgene Surge Higher?
Will the New Arthritis Drug Help Celgene Surge Higher? Wall St Cheat Sheet
View ArticleCelgene Vs. Rivals In Psoriatic Arthritis Drug Race
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race Seeking Alpha
View ArticleThe Psoriatic Arthritis Race: Celgene Vs. Johnson & Johnson
The Psoriatic Arthritis Race: Celgene Vs. Johnson & Johnson Seeking Alpha
View Article
